Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 15/20 | 0.54 |
| ▸ | KCNH2 | Q12809 | 11/20 | 0.54 |
| ▸ | CTSS | P25774 | 7/20 | 0.52 |
| ▸ | CTSB | P07858 | 3/20 | 0.52 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.48 |
| ▸ | CTSL | P07711 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3873580 | 0.88 | HRH3 (0.51) | CTSKKCNH2CTSSCTSBHRH3 | |
| Trifluoroacetic Acid SCHEMBL3877780 | 0.86 | CTSK (0.53) | CTSKKCNH2CTSSCTSBCTSL | |
| SCHEMBL8241648 | 0.85 | CTSK (0.56) | CTSKKCNH2CTSSCTSBCTSL | |
| SCHEMBL3875344 | 0.84 | CTSK (0.55) | CTSKKCNH2CTSSCTSBHRH3 | |
| SCHEMBL3875768 | 0.82 | CTSK (0.62) | CTSKKCNH2CTSSCTSBHRH3 | |
| SCHEMBL3878550 | 0.80 | CTSK (0.53) | CTSKKCNH2CTSSCTSBHRH3 | |
| SCHEMBL3873575 | 0.80 | CTSK (0.51) | CTSKCTSSHRH3ALDH1A1 | |
| SCHEMBL3873102 | 0.79 | CTSK (0.61) | CTSKKCNH2CTSSCTSBCTSL | |
| SCHEMBL3880950 | 0.79 | CTSK (0.54) | CTSKKCNH2CTSSCTSBCTSL | |
| Hydrochloric Acid SCHEMBL3885789 | 0.79 | CTSK (0.50) | CTSKCTSSHRH3ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1928842-B1 | 4-PHENYL-6-SUBSTITUTED-PYRIMIDINE-2-CARBONITRILE DERIVATIVES | ORGANON NV (NL) | 2009-11-18 | — | — | EP | disclosed |
| US-7326715-B2 | 4-Phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives | N.V. ORGANON (NL) | 2008-02-05 | — | — | US | disclosed |
| US-7326715-B2 | 4-Phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives | N.V. ORGANON (NL) | 2008-02-05 | — | — | US | disclosed |
| US-20070111992-A1 | 4-Phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives | N.V. ORGANON (NL) | 2007-05-17 | — | — | US | disclosed |
| US-20070111992-A1 | 4-Phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives | N.V. ORGANON (NL) | 2007-05-17 | — | — | US | disclosed |
| WO-2007039470-A1 | 4-PHENYL-6-SUBSTITUTED-PYRIMIDINE-2-CARBONITRILE DERIVATIVES | N.V. ORGANON (NL) | 2007-04-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070111992-A1 | 4-Phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives | CTSK, CTSS, CTSF | CTSK 1/4885KCNH2 2191/4885CTSS 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.